| Authors: |
Clement ME; Department of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA., Hanscom B; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Haines D; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bazan JA; Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA., Chotirosniramit N; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand., Kofron R; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA., Mannheimer S; Department of Medicine, Columbia University, NewYork, New York, USA., Mayer KH; Department of Medicine, Fenway Health and Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, USA., Torres Silva MS; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil., Soto-Torres L; Division of AIDS, National Institute of Allergy and Infectious Diseases, Rockville, Maryland, USA., Rinehart AR; Research and Development, ViiV Healthcare, London, UK., Rooney JF; Medical Affairs, Gilead Sciences, Inc, Foster City, California, USA., Jennings A; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., Gomez-Feliciano K; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., McCauley M; Network and Collaborative Research Division, FHI 360, Washington D.C., USA., Grinsztejn B; STI/HIV Clinical Research Laboratory, Evandro Chagas National Institute of Infectious Diseases-Fiocruz, Rio de Janeiro, Brazil., Landovitz RJ; Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. |
